Risks and Benefits of Infliximab for the Treatment of Crohn’s Disease

• 1 August 2006
• journal article
• research article
• Published by Elsevier in Clinical Gastroenterology and Hepatology
• Vol. 4  (8) , 1017-1024
• https://doi.org/10.1016/j.cgh.2006.05.020

Abstract

Keywords

• TREATMENT
• DECISION MAKING
• MODEL
• DEATH
• SURGERIES
• CROHN'S
• BENEFITS OF INFLIXIMAB
• QALYS/PATIENT